Comparer des méthodes

	Mesure de la qualité de vie liée au diabète (DQOL)	EORTC QLQ-C30
Domaine	Résultats de santé	Résultats de santé
Famille	Process / pipeline	Process / pipeline
Année d'origine	1988	1993
Auteur d'origine	Diabetes Control and Complications Trial Research Group	Nico Aaronson et al.
Type	Self-report quality of life questionnaire	Self-report quality of life questionnaire
Source fondatrice	The Diabetes Control and Complications Trial Research Group. (1988). The Diabetes Quality of Life (DQOL) measure. Diabetes Care, 11(10), 725-732.	Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376.
Alias	DQOL, Diabetes Quality of Life, Diabetes QOL	QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale
Apparentées	4	5
Résumé	The DQOL is a patient-reported measure of quality of life impact in people with diabetes. Developed by the Diabetes Control and Complications Trial (DCCT) Research Group in 1988, this 46-item questionnaire assesses how diabetes affects daily functioning, emotional well-being, worry about complications, and satisfaction with life and health. It is widely used in diabetes clinical trials and research to capture the burden of diabetes management and impact on psychosocial well-being.	The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.